BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SAW Instruments GmbH and ACOBIO K.K. Sign Exclusive Agreement to Distribute sam® Biosensors in Japan


12/13/2011 10:12:36 AM

Yokohama, Japan and Bonn, Germany – 13th December 2011: SAW Instruments, a developer of innovative biosensor technology for life sciences research, and ACOBIO K.K., have signed an exclusive agreement to allow ACOBIO K.K. to distribute SAW’s innovative sam® range of acoustic biosensors in Japan. The news ties in with the Japanese launch of the newest member of the series, the high-end sam®X, at the 34th Annual Meeting of the Molecular Biology Society of Japan (December 13-16). sam® systems provide a step-change in biosensor technology and applications, offering new capabilities for studying real-time kinetics on the surface of live mammalian cells. The new sam®X expands the flexibility, power and throughput available via an increase in the number of analysis channels and new adaptable microfluidic routing. ACOBIO K.K., which is owned by the Altair Corporation, was established in December 2011 to distribute innovative life science products in Japan.

Mr Eiji Takagi, former President of Biacore K.K. and new President of ACOBIO K.K., said: “Using our extensive experience in the pharmaceutical and biotechnology industries, ACOBIO’s mission is to make innovative life science technology and products from across the globe available for use by academia and industry in Japan. We are particularly pleased to have signed this agreement with SAW Instruments, as the company’s novel range of sam® biosensors open up new avenues for studying molecular interactions on the surface of mammalian cells.” Unlike other cell-based detection platforms, sam® acoustic biosensors do not require any fluorescent labelling, are real-time rather than steady-state, and can use unfixed cells adhered to the sensor surface or in suspension, all while providing rapid analysis in the order of only a few minutes. Dr Markus Perpeet, Managing Director of SAW Instruments, commented: “We are very pleased that our innovative sam® systems, which have already proven highly popular with researchers in Europe and the US, will now be available in Japan, and encourage Japanese researchers to see our new sam®X biosensor in action by visiting the ACOBIO K.K. booth at the Molecular Biology Society of Japan meeting.” The new system offers increased throughput with two sensor chips, rather than the single chip of the sam®5 models, subsequently increasing the number of available channels to eight. Using sophisticated fluidics, each channel can now be utilised independently (8 x 1) or via sequential combinations of 4 x 2, 2 x 4, or 1 x 8 channels, optimising user workflow and facilitating flexible assay design. Like the other members of the sam® family, the sam®X is ideal for measuring binding constants and kinetics at the surface of whole mammalian cells, as it generates highly accurate results significantly faster than similar equilibrium-based methods. For more information on the sam®X and the sam® family of biosensors, visit the ACOBIO K.K. stand at the 34th Annual Meeting of the Molecular Biology Society of Japan, or go to www.saw-instruments.com.

Notes on the technology

Surface Acoustic Wave technology is based on the ability of a wave of energy to travel across the surface of a material. Each surface has a typical inherent elasticity affecting the way the energy of the wave dissipates as it travels across the surface of the material being analysed. Thus, the nature of the surface in question, and therefore any changes to it, can be assessed by sensors monitoring the behaviour of the wave as it propagates across the surface. In particular, changes in mass result in alterations to the phase of the wave, whilst viscoelastic and conformational characteristics influence wave amplitude. The technology developed and employed by SAW instruments is capable of accurately interpreting this information in order to provide real time readouts measuring binding and conformational changes in the samples through which the wave passes.

About SAW Instruments GmbH

SAW Instruments GmbH designs, develops and sells biosensor-based laboratory instruments for life sciences research. The proprietary technology of SAW Instruments employs a Surface Acoustic Waves approach to biological measurement, rather than using traditional optical methods such as SPR. The technology is uniquely positioned compared to other biosensor technologies based on its ability to measure conformational changes in cells, membranes and vesicles. In addition, the system is also capable of providing other industry standard measurements including those involving kinetics, quantitation and affinity.

SAW instruments is a German company with more than ten years experience in the field of label-free biosensor technology and a number of our customers have successfully published work employing the platform. It is our goal is to continue to build on this experience, as well as to develop a family of workflow-driven products to further meet our customers’ needs.

About ACOBIO K.K.

ACOBIO K.K. was established on December 7, 2011 for the sale of instruments used for Life Science Research and Drug Development in Japan. The company’s mission is to introduce innovative technology and products from global supply sources to contribute to the development of the life science industry and academia in Japan.

ACOBIO K.K. is 100% owned by the Altair Corporation, Japan, a company that has over 30 years of experience in the sale and distribution of Biotechnology instruments in Japan. The president of ACOBIO K.K. is Mr. E. Takagi, former president of Biacore K.K.

Address: 23-3 Shinyokohama 3-Chome Kohoku-Ku Yokohama 222-0033 Japan

Phone number: 81-45-473-7661



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES